Search results (6)
« Back to NewsThe latest news, stories and exciting findings from across the Oxford cancer research community
MP Anneliese Dodds tours Oxford cancer research
26 November 2021
Anneliese Dodds, MP for Oxford East & Chair of the Labour Party, visited the University of Oxford to learn more about the impactful work happening across departments in the field of cancer research.
Anti-cancer drug derived from fungus shows promise in clinical trials
6 October 2021
A new industry-academic partnership between the University of Oxford and biopharmaceutical company NuCana as found that chemotherapy drug NUC-7738, derived from a Himalayan fungus, has 40 times greater potency for killing cancer cells than its parent compound.
Using Herpesvirus to fight cancer
26 April 2021
The Seymour lab at the Department of Oncology, University of Oxford, has published a new paper investigating the use of oncolytic herpes virus-1 as a vector to augment immunotherapy in cancer
Novel imaging device enters first round of development funding programme
29 March 2021
Anna Vella is designing CAPULET: a device to increase the accuracy in delivering particle beam radiotherapy in cancer treatment
Oxford spin out financed $6.8m for research into oncolytic therapies
7 January 2021
Oxford spin out company Theolytics has closed a $6.8m deal to support their work into developing novel cancer therapies from viruses
Innovative drug delivery techniques show promise in clinical trials
2 November 2020
Dr Laura Spiers talks about the TarDox and PanDox trials, which are using novel drug delivery techniques to improve the uptake of chemotherapy drugs into pancreatic tumours and other cancers